Entera Total Revenue from 2010 to 2024

ENTX Stock  USD 1.59  0.03  1.85%   
Entera Bio Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue will likely drop to about 13.3 K in 2024. Total Revenue is the total amount of income generated by the sale of goods or services related to Entera Bio's primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2015-12-31
Previous Quarter
57 K
Current Value
42 K
Quarterly Volatility
777 K
 
Yuan Drop
 
Covid
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Total Revenue Growth Pattern

Below is the plot of the Total Revenue of Entera Bio over the last few years. Total revenue comprises all receipts Entera Bio generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. Entera Bio's Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

Entera Total Revenue Regression Statistics

Arithmetic Mean122,220
Geometric Mean0.00
Coefficient Of Variation163.53
Mean Deviation159,320
Median0.00
Standard Deviation199,862
Sample Variance39.9B
Range571K
R-Value0.42
Mean Square Error35.6B
R-Squared0.17
Significance0.12
Slope18,565
Total Sum of Squares559.2B

Entera Total Revenue History

202413.3 K
202314 K
2022134 K
2021571 K
2020365 K
2019236 K
2018500 K

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue14 K13.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.